Early changes in parameters of bone and mineral metabolism during therapy for hyper- and hypothyroidism

Endocrine Research

Volumn 27, Issue 1-2, 2001, Pages 203-213

  Sabuncu, T ^a   Aksoy, N ^a   Arikan, E ^a   Ugur, B ^a   Tasan, E ^a   Hatemi, H ^a  

^a Rahmet Apartment   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; LEVOTHYROXINE; LIOTHYRONINE; PARATHYROID HORMONE; PROPYLTHIOURACIL; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; ARTICLE; BONE METABOLISM; BONE MINERAL; CONTROLLED STUDY; GRAVES DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; PRIORITY JOURNAL; THYROID ADENOMA; THYROID DISEASE; TOXIC GOITER;

ADULT; AGING; ALKALINE PHOSPHATASE; AMINO ACIDS; BODY MASS INDEX; BONE AND BONES; CALCIUM; CREATININE; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MENOPAUSE; MIDDLE AGED; MINERALS; PARATHYROID HORMONE; PHOSPHORUS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0034973356     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1081/ERC-100107181     Document Type: Article

References (35)

1. Thyroid hormones and bone
2. Bone changes in hyperthyroidism: Interrelationships between bone morphometry, thyroid function and calcium-phosphorus metabolism
3. Hyperthyroidism and calcium metabolism
4. Direct stimulation of bone resorption by thyroid hormones
5. The skeletal system in thyrotoxicosis
6. Exogenous hyperthyroidism with osteoporosis
7. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers
8. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism
9. Biochemical markers of bone turnover. Applications for osteoporosis
10. Biochemical markers of bone turnover
11. Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with Graves' thyrotoxicosis
12. Hydroxyproline excretion in the urine and calcium metabolism during long-term treatment of thyrotoxicosis with propylthiouracil
13. The skeletal system in hypothyroidism
14. Effects of thyroid hormones on bone and mineral metabolism
15. Secondary osteoporosis. Diagnostic considerations
16. Secondary osteoporosis
17. Markers of bone turnover in hyperthyroidism and the effects of treatment
18. Bone turnover and cortical bone mineral density in the distal radius in patients with hyperthyroidism being treated with antithyroid drugs for various periods of time
19. A therapeutic dilemma: Suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma
20. Bone mineral density in premenopausal women receiving long-term physiological doses of levothyroxine
21. Bone mineral density in postmenopausal women treated with L-thyroxine
22. Long-term thyroxine treatment and bone mineral density
23. Thyroid hormone use and bone mineral density in elderly women
24. Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy
25. Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy
26. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism
27. Decreased parathyroid function in hyperthyroidism: Interrelationships between serum parathyroid hormone, calcium-phosphorus metabolism and thyroid function
28. The thyroid gland
29. Osteoporosis
30. Thyrotoxicosis and hungry bone syndrome: A cause of posttreatment hypocalcemia
31. Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy
32. Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH
33. Pathogenesis of osteoporosis and fracture
34. Thyroid hormone treatment aiming at reduced, but not suppressed, serum thyroid-stimulating hormone levels in nontoxic goitre: Effects on bone metabolism amongst premenopausal women
35. Urinary excretion of pyridinoline and deoxypyridinoline measured by immunoassay in hypothyroidism